Seattle Children’s spins out BrainChild Bio, a startup developing therapies for incurable brain cancers
GeekWire
DECEMBER 5, 2023
The startup has an exclusive license to use novel CAR T-cell technology developed by Jensen and his team. “With our clinical trials and our academic programs, we can treat and help dozens or tens of dozens of patients,” Jensen said. Steven Brugger will join BrainChild Bio as CEO.
Let's personalize your content